chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Started having abdominal bloating in October, scan showed large ovaries and had increased CA125. Ended up being diagnosed with Apendiceal cancer and needed a large operation and chemo and hospitalization
Treatment of COVID 19; Treatment of COVID 19; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A 46-year-old female patient (not pregnant) received BNT162b2 (BNT162B2), on 27Feb2021 as dose 1, single (Lot number: EN6198), in left arm, on 20Mar2021 as dose 2, single (Lot number: ER2613), in left arm and on 11Nov2021 as dose 3 (booster), single (Lot number: EW0186-H) at the age of 46 years, in left arm for covid-19 immunisation. The patient had no relevant medical history. There were no concomitant medications. The following information was reported: VACCINATION FAILURE (medically significant) with onset 11Jul2022, outcome "unknown", COVID-19 (medically significant) with onset 11Jul2022, outcome "not recovered" and all described as "Treatment of COVID 19". The patient underwent the following laboratory tests and procedures: SARS-CoV-2 test: (18Jul2022) Positive line was dark; (20Jul2022) Positive line is still shown, notes: and still showed a dark line before reaching the control line; (11Jul2022) Positive; (17Jul2022) Faint positive line. Therapeutic measures were taken as a result of vaccination failure, covid-19. Clinical information includes the patient was not taking any other medications/products within 2 weeks of starting COVID-19 treatment. The patient had previously received a COVID-19 Vaccine. The patient was tested positive on 11Jul2022 using a home antigen test and started taking Paxlovid on 11Jul2022 through the 5 days and symptoms quickly resolved, feeling better just 2 days later. The patient started feeling symptoms again on 19Jul2022 and antigen test on Sunday morning, 17Jul2022 showed a faint positive line. Beginning on Monday, 18Jul2022, the positive line was dark and showed positive before reaching the control line on the test. On Wednesday, 20Jul2022, the positive line is still shown and still showed a dark line before reaching the control line. The Adverse event start date for Paxlovid was on 19Jul2022 which resulted in none of the serious criteria and not recovered yet. The patient did not receive any treatment for the event with Paxlovid.  No follow-up attempts are possible. No further information is expected.
Initial report was received from a consumer on 03 January 2012. A 19-year-old female patient had received an Intramuscular (IM) injection of FLUZONE; lot number UH454AA in left deltoid on 02 January 2012. On 03 January 2012, the patient developed a rash on her chest and stomach. The patient was diagnosed by her physician with pityriasis. The patient corrective treatment was not reported. No further informational was available at the time of the report. The patient outcome was reported as not recovered/not resolved. Documents held by sender: None.
We think three minutes after vaccination I experienced dizziness losing my site also hot sensation from head to toe, the nurse came and she was afraid I was having a stroke so was I because I had strokes before and I knew that this was an indication of a stroke. I experience this for three times within 30 minutes . For the following two weeks I felt nauseous very dizzy could not concentrate headaches and very weak. I know that this was a TIA because of past experiences, still not completely recovered. So I decided not to do the second dose I am afraid for a major stroke.
Mild itching with second vaccine, no reported reaction to the first vaccine. EMS treated with 25 mg of oral Benadryl, and she reported relief felt.  Per EMS vitals stable. No transport.
Out at lunch @ 12:30 pm at restaurant. Had not eaten that morning. Had just taken 2nd morning dose of Carbidopa/Levodopa at table. Began to feel light headed. attempted to walk to car. Passed out but quickly revived. Transported by ambulance to local hospital ER. Physician review of blood labs identified low blood pressure, low potassium, low platelets levels. Was provided 2 potassium pills, advised to do follow-up with Neurologist and Primary Physician.  Neurologist said that both Parkinson's medications and prostate medications could contribute to low blood pressure and did not recommend change in current medications.  Primary Physician took another blood test and identified that all test results were normal.  Primary Physician asked that I take AM + PM blood pressure over a 10-day period.  BP results were normal.  A 3rd blood panel test was taken 2 days ago to recertify results of 2nd test.  Awaiting results.
PATIENT REPORTED INJECTION SITE REACTION IN LEFT ARM AFTER VACCINATION EVENING OF BEING VACCINATED ON 9/6/16. REDNESS, SORENESS, INFLAMMATION, ITCHING, AND SWELLING. PATIENT REPORTS SWELLING HAS GONE DOWN SINCE 9/6 BUT REDNESS HAS MOVED FROM INJECTION SITE DOWN INTO BICEP OF ARM. PATIENT REPORTS TAKING THE FOLLOWING ACTION AT HOME WITH SELF-CARE: PAIN MEDICATION, BENADRYL, AND PLACING ICE ON THE INJECTION SITE.
No additional AE reported.; Inadvertently administered post expiration; This spontaneous repot was received from a certified medical assistant and refers to a patient of unknown age and gender. No information regarding the patient's medical history, concurrent conditions or concomitant medications was reported.  On 22-SEP-2021, the patient was vaccinated with an expired dose of varicella virus vaccine live (Oka/Merck) (VARIVAX) 0.5 milliliter, once,  lot # S019581 was confirmed to be valid, expiration date 25-JUN-2021, for prophylaxis (route and site of administration were not reported). No additional adverse event was reported.
Pt with hx of mild tremors. Developed worsening tremors 2 weeks after vaccination. He is a MD and would like to speak with CDC.
Patient received first dose of Pfizer on 4/16/2021 and then received second dose of Pfizer early on 4/28/2021.  The second dose was administered by LPN and it was reported to the provider at the site after administration.  No adverse reaction noted after the vaccine was given.
8/19 rt axillary pain, went to gymnastics practice for 3 1/2 hrs, no upper body work out, took alieve 200 mg after due to continued soreness, 8/20 progressive rt axilla and chest wall swelling and pain, not better with warm compresses, ibuprofen 200 mg,  worse 8/21, no fever, no redness, no other sx's, injection site nl, seen by me on 8/21, referred to ER for further evaluation by Dr.,  dx  localized swelling chest wall, possible lymphadenitis, rx clindamycin 300 mg tid x 10 days,  pain and swelling  improved after 3 doses when seen by me on 8/24, all sx's resolved by 8th day of antibx per parent report, did not return for recheck visit,
Mother reported that several weeks after 4/15/03 immunizations, the infant began limping on right leg and then crawling on hands and knees to avoid walking.  No fever or other sx. She saw pediatrician on 5/20/03.  Dx: arthralgia. Motrin ordered. Symptoms resolved. Mother stated that the pediatrician thought it was related to the MMR vaccine and that it would resolve on its own.
Day 1-dizziness, headache, fever, sore arm, sore underarm, exhaustion, nausea, cold chills  (Tylenol, ice pack for head and arm) Day 2-headache, fever, sore arm, extremely painful underarm (lymph node) area, fatigue, nausea, cold chills (Tylenol, ice pack for lymph node area, cold washcloth for arm and head, broth for nausea) Day 3-headache, fever sore arm, underarm area somewhat better, fatigue, nausea, chilled (Tylenol, ice pack for underarm area, cold washcloth for head, broth) Day 4-headache a little better, fever, sore arm, underarm area better, fatigue, nausea (Tylenol, cold washcloth for head, broth) Day 5-slight headache, sore arm, fatigue, nausea somewhat better (broth) Day 6-fatigue, slightly sore arm, slight nausea Day 7-arm still sore, slight fatigue First month-every now and then  a slight twinge in my underarm (lymph node) area
Large circular red rash around injection site, very itchy, and the skin was markedly hotter in that area than in other areas of the arm. Faded and become less itchy and hot after about three days.
Injection at 8am. At 4:45pm came an onsite of mild chills and general sluggish feeling At 5:38pm, body aches, muscle aches, joint pain at 6:30 pm, worsening feeling and with fever 7pm, profuse sweating with chills, body aches, fever 11:35pm-began to come out of it  10am next day, mostly finished and able to remain working.
"After my Covid shot, my right hand started tingling. I told the nurse that it was tingling. I waited 15 min. I left and went to work. As I was doing my job, my hand started tingling again. I went to Occupational health, and was sent to the emergency room. They recommended that I see my doctor."
6/23/17, 10:00 AM - nausea. 6/23/17, 3:00 PM - fatigue. 6/23/17, 5:30 PM - sore throat, stuffy nose. 6/24/17, 6:00 AM - severe fatigue, headache, loss of appetite, severe nausea, weakness. 6/24/17 7:00 AM - vomiting then sleeping. 6/24/17 12:30 PM - vomiting then sleeping. 6/24/17 2:30 PM - weakness, nausea, continued loss of appetite. 6/24/17 7:30 PM - sleep. 6/25/17 6:00 AM - headache, nausea, weakness, tiredness. 6/25/17 9:00 AM - ate a slice of bread and took an ibuprofen. 6/25/17 10:00 AM - headache abated and nausea calmed. 6/25/17 11:00 AM - appetite returned. 6/25/17 3:30 PM - diarrhea, mostly weak and tired for rest of day. 6/26/17 6:00 AM - fatigue.
This spontaneous case was reported by a consumer and describes the occurrence of HYPERHIDROSIS (broke into a sweat with no fever, like pushing something out of the body), DECREASED APPETITE (very little appetite), PAIN (a lot of pain) and COUGH (coughing) in a male patient of an unknown age who received mRNA-1273 (Spikevax) for COVID-19 vaccination. No Medical History information was reported. On an unknown date, the patient received dose of mRNA-1273 (Spikevax) (unknown route) 1 dosage form. On an unknown date, the patient experienced HYPERHIDROSIS (broke into a sweat with no fever, like pushing something out of the body), DECREASED APPETITE (very little appetite), PAIN (a lot of pain) and COUGH (coughing). The patient was treated with MENTHOL (VICKS COUGH [MENTHOL]) for Coughing, at an unspecified dose and frequency. At the time of the report, HYPERHIDROSIS (broke into a sweat with no fever, like pushing something out of the body), DECREASED APPETITE (very little appetite), PAIN (a lot of pain) and COUGH (coughing) had resolved. The action taken with mRNA-1273 (Spikevax) (Unknown) was unknown. No concomitant medication information was provided. It was reported that the patient's mother answered the phone and replied that the patient had left for work, but the patient would have asked two questions. The patient's mother was instructed to ask the two questions and was adamant that the patient's mother did not want to provide any other information. The patient had experienced symptoms for two days and wanted to know whether it was normal to have such symptoms after the vaccination or not. The patient wanted to know if receiving the booster shot might affect the patient's mother or not. Reporter did not allow further contact
Information has been received from a licenses practical nurse concerning a female pt who in 1998 was vaccinated with a first and second dose of Hep B. Subsequently, after each dose, the pt experienced a fever and vomiting that was described as severe. Additional information has been requested.
hot feeling; bruising/ still brushied; Swollen; sore arm; This non-serious case was reported by a consumer via interactive digital media and described the occurrence of pain in arm in a patient who received Herpes zoster (Shingles vaccine) for prophylaxis.   On 12-JUN-2023, the patient received the 2nd dose of Shingles vaccine. In JUN-2023, an unknown time after receiving Shingles vaccine, the patient experienced pain in arm (Verbatim: sore arm). On 15-JUN-2023, the patient experienced feeling hot (Verbatim: hot feeling), contusion (Verbatim: bruising/ still brushied) and swelling (Verbatim: Swollen). The outcome of the pain in arm and contusion were not resolved and the outcome of the feeling hot and swelling were not reported.   It was unknown if the reporter considered the pain in arm, feeling hot, contusion and swelling to be related to Shingles vaccine.     It was unknown if the company considered the pain in arm, feeling hot, contusion and swelling to be related to Shingles vaccine.   Additional Information: GSK receipt date: 16-Jun-2023 and 19-Jun-2023 This case was reported the patient via interactive digital media. The patient just got shingles shot on Monday evening, and on June 15 2023, was feeling hot, swollen, bruised and still bruised. The patient arm was sore arm. The patient was glad to got the 2nd one and then no more, but it was over and arm would be better soon. Follow-up not possible as no contact details provided.
This case was reported by a healthcare professional (nurse) and described the occurrence of swelling injection site in a 31-month-old male subject who was vaccinated with PEDIARIX (GlaxoSmithKline). On 3 December 2012 at 15:45 the subject received 1st dose of PEDIARIX (.5 ml, unknown route, left thigh). On 3 December 2012, immediately after vaccination with PEDIARIX, the subject experienced swelling injection site ("swollen leg") and redness of leg of injection site ("red leg"). The nurse reported that the "parents complained of a left swollen leg." At the time of reporting the outcome of the events were unknown. The reporter stated that no additional information was known at this time. The nurse reported two subjects with adverse events. See case A1004928A for details on the other case. Follow up received from healthcare professional (medical assistant) on 16 January, 2013. The healthcare professional documented that the subject was 19 months old at the time of vaccination with PEDIARIX. On 3 December 2012, all events had resolved. The healthcare professional did not consider the events serious. The subject had not experienced adverse events following previous vaccinations. The medical assistant documented that this case had been reported to a regulatory agency.
This case was considered medically important. Additional information provided patient demographics, dose details, suspect vaccine, events details, outcome and test results. Information regarding PREVNAR 13 was received from a healthcare professional regarding a 7-month-old male patient who experienced possible allergic reaction and rash starting on thigh and spreading to the whole body. The patient received the first dose on 12-May-2010. Additional suspect medication included Hepatitis B Vaccine. The patient experienced possible allergic reaction and rash starting on thigh and spreading to the whole body on 12-May-2010. The patient recovered. No additional information was available at the time of this report.
rash on face, chest, abdomen,  warm and itchy skin blurred vision Itchy throat Took 50 Benadryl orally 2 hour post injection around 9p,.
50 1/2x70cm RA rash from varicella. Give pt 5mg of Benadryl and ice pack.
Progressive resurgence of facial neuropathy that was well controlled prior to the first vaccine. Severity is similar to at its worst.
My wife had several blood clots in both lungs. She is now on blood thinners after spending 1 week in the hospital.
Headache all day, neck hurts, and stomach ache.  Tylenol around 10:00 AM, and Motrin in the afternoon did not releave headache.
Pt. given 50 mg of Benadryl by mom, rested in room, checked frequently and states he is feeling better now. Pt. left home with mom. No respiratory distress.
Information has been received from a licensed practical nurse concerning a 17 year old female with allergy to codeine and a history of Lyme disease and chronic ear infection as a baby who on 14-MAY-2008 was vaccinated with her first 0.5 ml IM dose of GARDASIL (lot # 659964/1978U), her second 0.5 ml IM dose of GARDASIL (Lot# 659054/0315Y) on 20-MAY-2009 and her third 0.5 ml IM dose of GARDASIL (Lot# 665266/1378Y) on 10-MAR-2010. The patient did not receive any concomitant vaccination on 10-MAR-2010. There was no concomitant medication. On 15-MAR-2010 the patient developed soreness/discomfort at the injection site on the left arm, she was crying in pain which was getting worse, and developed erythema that "comes and goes". The patient was seen by the physician on two occasions, once in the morning (AM) and again in the afternoon (PM). She was started on AUGMENTIN. The patient went to the emergency room (ER) and was not admitted to the hospital. On 16-MAR-2010 the patient was seen by the physician in the morning (AM). She was seen in the emergency room for increasing pain. She had "lots of swelling" in her left arm. Her right arm circumference was 11 inches but the left arm was 12.75 inches. A CT scan of the arm was performed which revealed a possible abscess forming which was later confirmed. Therapy with AUGMENTIN was discontinued and the patient was started on KEFLEX and BACTRIM. The patient returned to the doctor's office in the afternoon. The pain was worse and swelling the same. She was admitted to the hospital for pain control and possible incision and drainage of site. The patient was hospitalized for three days. On 18-MAR-2010 the patient had an incision and drainage of the abscess which was 9.8 cm x 3 cm x 5 cm, with 2 ounces of fluid removed. On 19-MAR-2010 the patient was discharged from the hospital. On 23-MAR-2010 the patient was seen by the physician for a follow-up physician's visit. She also had a follow-up visit with the Pediatric surgeon. The patient did not have another scheduled follow-up appointment with the physician. At the time of the report, the patient was recovering. It was also reported that the physician was concerned about similar adverse events related to the lot of the last dose of GARDASIL. The L.P.N. requested a lot check for lot# 665266/1378Y. The reporter considered possible abscess which was later confirmed, left arm was sore at injection site, crying in pain, increasing pain, erythema that comes and goes and swelling in her left arm to be other important medical events. A lot check has been initiated. Additional information has been requested.
sleepy after second shot; tired after second shot; This spontaneous case was reported by a consumer and describes the occurrence of SOMNOLENCE (sleepy after second shot) and FATIGUE (tired after second shot) in a 58-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 003A21A and 030M20A) for COVID-19 vaccination.     No Medical History information was reported.   On 12-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 01-Mar-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 11-Mar-2021, the patient experienced SOMNOLENCE (sleepy after second shot) and FATIGUE (tired after second shot). At the time of the report, SOMNOLENCE (sleepy after second shot) and FATIGUE (tired after second shot) outcome was unknown.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   No relevant concomitant medications were reported. No treatment information was provided.
Pt vaccinated with MMR developed malaise, fever, adenopathy, w/abnormal liver function test, dx acute hepatitis.
arm sore; difficulty in going out of bed; fever; headache; chills; This spontaneous case was reported by a consumer (subsequently medically confirmed) and describes the occurrence of PAIN IN EXTREMITY (arm sore), CLINOMANIA (difficulty in going out of bed), PYREXIA (fever), HEADACHE (headache) and CHILLS (chills) in a 68-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 012M20A and 011L02A) for COVID-19 vaccination.     Concomitant products included FLUOXETINE, ROSUVASTATIN, AMLODIPINE, CALCIUM, VITAMIN D [VITAMIN D NOS] and VITAMIN B NOS for an unknown indication.   On 02-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 31-Jan-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1. On 31-Jan-2021, the patient experienced PYREXIA (fever), HEADACHE (headache) and CHILLS (chills). On 01-Feb-2021, the patient experienced PAIN IN EXTREMITY (arm sore) and CLINOMANIA (difficulty in going out of bed). At the time of the report, PAIN IN EXTREMITY (arm sore), CLINOMANIA (difficulty in going out of bed), PYREXIA (fever), HEADACHE (headache) and CHILLS (chills) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): In January 2020, White blood cell count (3.8-10.8): Low. In June 2020, White blood cell count (3.8-10.8): Low. On 14-Jan-2021, White blood cell count (3.8-10.8): 3.7 Low. On an unknown date, Body temperature: (High) 101F.     For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   This case was linked to MOD-2021-216190 (Patient Link).; Reporter's Comments: Her treating physician referred that her WBC low is normal for her.
The entire right arm is hurting on movement and is sore; Mild Diarrhea; Pain on the injection site; Mild headache; A spontaneous report was received from a 62-year-old female patient who participated in the mRNA-1273 Emergency Use Program and experienced pain on the injection site, right arm pain and soreness, a mild headache, and diarrhea.  The patient's medical history was not reported.  No relevant concomitant medications were reported.  The patient received their first of two planned doses of mRNA-1273 intramuscularly in the right deltoid for prophylaxis of COVID-19 infection on 29 Dec 2020.  On 30 Dec 2020, the patient experienced pain on the injection site, right arm pain and soreness, a mild headache, and diarrhea. No treatment information was provided.  Action taken with mRNA-1273 in response to the events was not reported.  The outcome of the events was not reported.; Reporter's Comments: This case concerns a 62-year-old female who experienced NS unexpected events of pain in extremity and diarrhea and NS expected events of injection site pain and headache.  Event onset occurred on Day 2 after the first dose of mRNA-1273. Treatment not reported. Event outcome known. Based on current available information and temporal association between the use of the product and the start date of the event, a causal relationship cannot be excluded.
Client received the smallpox vaccine on 03/04/03.  Around the 1st of April, 2003, client developed "fluttering" sensations of the heart.  No previous heart problems prior to 4/03.  Had stress test and echo cardiogram on 4/14/03- Heart cath performed on 4/22/03.  Results of heart cath:  Blocked left ventricle 99.9% blockage of the coronary artery.  Stint was inserted during the heart cath on 4/22/03.   Client was hospitalized x 2 days.  Heart cath and stint was performed by Dr. -  Follow-up care is being done. Follow up on 12/09/03: "Pt underwent full cardiac work up and catherization revealed coronary blockage.  Pt was stented.  Any possible relationship to this pt's findings that the vaccine are unclear."
pt has been on humira for 2 years then states it stopped working (still works, but not as before) onset began after second covid vaccine in july 2021. md is aware and md will change medication in february 2022. spontaneous report. no further information provided.